Nicox says Pfizer drops glaucoma drug study in Asia
PARIS (Reuters) - French biotechnology firm Nicox said on Monday U.S. partner Pfizer had decided not to launch Phase III studies in Asia of an experimental treatment of glaucoma and ocular hypertension. 3 months ago
Reuters Click here to Read the Full Story
Digg
del.icio.us
Reddit
Stumble
Newsvine
Facebook